SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CardioThoracic Systems (CTSI)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Norm Franklin who wrote (118)9/19/1997 11:59:00 AM
From: Bob Jagow   of 207
 
You're, not missing anything, Norm.
I said the opposite of "CTSI survival is promoted if stents are shown to be as successful as bypasses"
Re-read "The only way they compete with HPRT IMO is with success of Access MV; may be only way they survive if it is shown that a stent is as long-lived as a bypass."
That is, they have nothing going for them in their present single-bypass mode if stents are shown to be as successful as bypasses.

There is BTW a lot of useful info re much of this at heartport.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News